Bipartisan legislation aimed at capping the cost of insulin at $35 per month for individuals with private insurance is gaining traction. The bill, which was introduced in March, received support from four additional co-sponsors on Monday, including Senators Joni Ernst (R-Iowa) and John Hickenlooper (D-Colo.).
✓ AI-Debiased Article
30
Mainstream framing
L
R
No clear lean
✓ verified
Bipartisan Legislation to Cap Insulin Costs Gains Support
A bipartisan bill to limit insulin costs to $35 per month for those with private insurance is gaining support, with four new co-sponsors added recently. The legislation was first introduced in March.
People
Joni Ernst
John Hickenlooper
Annotating as
No note attached
on this article.
Bias Analysis
Bias score
30/100
wirepublicmainstream
flavoredpartisanadvocacy
Inflammatory language
10/100
Sentiment
+20/100
Bias Indicators Removed
- ✕ framing: headline asserting a conclusion
Original vs. Neutral
Original Headline
Insulin legislation gains steam
Neutral Headline
Bipartisan Legislation to Cap Insulin Costs Gains Support
